Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Recursion Pharmaceuticals (NASDAQ: RXRX ) reported second-quarter financial results on Wednesday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Recursion Pharma
Big Technologies said H1 2026 included 5% ARR growth, strong contract wins in the US and Latin America, and retention with an adjusted EBITDA margin of 53%. The company also cited robust cash generation and an outlook for continued growth into 2027.